CS logo
small CS logo
Center for the Treatment and Study of Anxiety, University of Pennsylvania

Philadelphia, Pennsylvania, United States
Research institute in Philadelphia, Pennsylvania
6th Gateway, 3535 Market St, Philadelphia, PA 19104

About Center for the Treatment and Study of Anxiety, University of Pennsylvania


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Center for the Treatment and Study of Anxiety, University of Pennsylvania


During the past decade, Center for the Treatment and Study of Anxiety, University of Pennsylvania conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Center for the Treatment and Study of Anxiety, University of Pennsylvania" #1 collaborator was "National Institute of Mental Health (NIMH)" with 7 trials as a collaborator, "University of Texas" with 2 trials as a collaborator, "VA Palo Alto Health Care System" with 2 trials as a collaborator, "The University of Texas Health Science Center at San Antonio" with 1 trials as a collaborator and "U.S. Army Medical Research and Development Command" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Center for the Treatment and Study of Anxiety, University of Pennsylvania


According to Clinical.Site data, the most researched conditions in "Center for the Treatment and Study of Anxiety, University of Pennsylvania" are "Combat Disorders" (3 trials), "Obsessive-Compulsive Disorder" (2 trials), "Posttraumatic Stress Disorder" (2 trials), "Posttraumatic Stress Disorders" (2 trials) and "Obsessive Compulsive Disorder" (1 trials). Many other conditions were trialed in "Center for the Treatment and Study of Anxiety, University of Pennsylvania" in a lesser frequency.

Clinical Trials Intervention Types at Center for the Treatment and Study of Anxiety, University of Pennsylvania


Most popular intervention types in "Center for the Treatment and Study of Anxiety, University of Pennsylvania" are "Behavioral" (10 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Prolonged Exposure Therapy" (2 trials), "Web-PE Therapy" (2 trials), "Cognitive-Behavior Therapy" (1 trials), "Control condition" (1 trials) and "Exposure and Ritual Prevention (Cognitive Behavioral Therapy)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Center for the Treatment and Study of Anxiety, University of Pennsylvania


The vast majority of trials in "Center for the Treatment and Study of Anxiety, University of Pennsylvania" are 9 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Center for the Treatment and Study of Anxiety, University of Pennsylvania


Currently, there are NaN active trials in "Center for the Treatment and Study of Anxiety, University of Pennsylvania". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Center for the Treatment and Study of Anxiety, University of Pennsylvania, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Center for the Treatment and Study of Anxiety, University of Pennsylvania, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".